Scientific Online Resource System

Scripta Scientifica Medica

Percutaneous edge to edge mitraclip therapy in the management of mitral regurgitation

Trayan Botev Tsvetkov, Svetoslav Georgiev

Abstract

Mitral valve regurgitation (MR) is an important clinical issue as MR represents >30% of native valve diseases. Patients with symptomatic MR have a poor prognosis, with a 5% annual mortality rate in the absence of surgery. Optimal medical management can improve symptoms of heart failure but does not affect survival. Therefore, surgery is recommended by the current guidelines for patients with symptomatic severe MR or asymptomatic severe MR with evidence of left ventricular (LV) dysfunction or dilation. Despite  guidelines, a recent European survey established that one-half of the patients are not referred for surgery, mainly because of advanced age and the presence of comorbidity. Mitral valve (MV) repair is the preferred surgical strategy whenever feasible and is associated with lower morbidity and mortality and better preservation of LV function, compared with MV replacement . Reported in-hospital mortality rates range from 1% to 2% in low-risk patients, increasing up to 25% in high-risk or elderly patients. Therefore, new percutaneous techniques are developed to avoid surgery in high-risk patients.

Keywords

mitral; regurgitation; mitraclip;

Full Text


References

Carabello BA.The current therapy for mitral regurgitation. J Am Coll Cardiol, 2008;52:319-326.

Feldman T, HS Wasserman, HC Herrmann, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST phase I clinical trial. J Am Coll Cardiol, 2005;46:2134-2140.

Feldman T, S Kar, M Rinaldi, et al., EVEREST Investigators. Percutaneous mitral repair with the MitraClip system: safety and mid-term durability in the initial EVEREST (Endovascular Valve Edge-to-Edge Repair Study) cohort. J Am Coll Cardiol, 2009;54:686-694.

Herrmann HC, S Kar, R Siegel, et al. EVEREST Investigators. Effect of percutaneous mitral repair with the MitraClip device on mitral valve area and gradient. EuroIntervention, 2009;4:437-442.

Tamburino C, GP Ussia, F Maisano et al. Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting. Eur Heart J, 2010;31:1382-1389.

Van den Branden BJ, MC Post, MJ Swaans, et al. Percutaneous mitral valve repair using the edge-to-edge technique in a high-risk population. Neth Heart J, 2010;18:437-443.




DOI: http://dx.doi.org/10.14748/ssm.v47i1.1003
Article Tools
Email this article (Login required)
About The Authors

Trayan Botev Tsvetkov
Medical University of Varna
Bulgaria

IInd Cardiology Department  UH "St Marina" Varna / Bulgaria

Svetoslav Georgiev
Medical university of Varna
Bulgaria

IInd Cardiology department, St. Marina

Font Size


|